Approach to congenital heart diseases (cyanotic): Clinical sciences

2,578views

Approach to congenital heart diseases (cyanotic): Clinical sciences

Topics for Physical Assessment

Topics for Physical Assessment

Approach to skin and soft tissue lesions: Clinical sciences
Approach to skin and soft tissue infections: Clinical sciences
Approach to skin and soft tissue injury: Clinical sciences
Approach to common skin rashes: Clinical sciences
Approach to a rash in the well newborn and infant: Clinical sciences
Approach to viral exanthems (pediatrics): Clinical sciences
Herpes zoster infection (shingles): Clinical sciences
Approach to anxiety disorders: Clinical sciences
Approach to sleep disorders: Clinical sciences
Approach to mood disorders: Clinical sciences
Approach to trauma and stressor-related disorders: Clinical sciences
Approach to a fever (0-60 days): Clinical sciences
Approach to a fever (over 2 months): Clinical sciences
Approach to a fever: Clinical sciences
Approach to growth faltering: Clinical sciences
Approach to back pain: Clinical sciences
Approach to joint pain and swelling: Clinical sciences
Approach to hip pain: Clinical sciences
Approach to foot pain: Clinical sciences
Approach to ankle pain: Clinical sciences
Approach to shoulder pain: Clinical sciences
Approach to knee pain: Clinical sciences
Approach to common musculoskeletal injuries (pediatrics): Clinical sciences
Juvenile idiopathic arthritis: Clinical sciences
Legg-Calve-Perthes disease and slipped capital femoral epiphysis: Clinical sciences
Developmental dysplasia of the hip: Clinical sciences
Approach to headache or facial pain: Clinical sciences
Concussion and traumatic brain injury
Approach to dizziness and vertigo: Clinical sciences
Approach to altered mental status: Clinical sciences
Approach to involuntary movements: Clinical sciences
Approach to tremor: Clinical sciences
Approach to polyneuropathy: Clinical sciences
Approach to acute vision loss: Clinical sciences
Approach to a red eye: Clinical sciences
Approach to facial palsy: Clinical sciences
Approach to amblyopia and strabismus (pediatrics): Clinical sciences
Eyelid disorders: Clinical sciences
Approach to head and neck masses (pediatrics): Clinical sciences
Approach to leukocoria (pediatrics): Clinical sciences
Approach to diplopia: Clinical sciences
Approach to peripheral lymphadenopathy (pediatrics): Clinical sciences
Approach to peripheral lymphadenopathy: Clinical sciences
Upper respiratory tract infection
Upper respiratory tract infections: Clinical sciences
Otitis media and externa (pediatrics): Clinical sciences
Allergic rhinitis: Clinical sciences
Influenza: Clinical sciences
Pharyngitis, peritonsillar abscess, and retropharyngeal abscess (pediatrics): Clinical sciences
Croup and epiglottitis: Clinical sciences
Acute group A streptococcal infections and sequelae (pediatrics): Clinical sciences
Infectious mononucleosis: Clinical sciences
Approach to a cough (acute): Clinical sciences
Approach to a cough (subacute and chronic): Clinical sciences
Atelectasis: Clinical sciences
COVID-19: Clinical sciences
Asthma: Clinical sciences
Bronchiolitis: Clinical sciences
Community-acquired pneumonia: Clinical sciences
Chronic obstructive pulmonary disease: Clinical sciences
Developmental milestones (newborn and infant): Clinical sciences
Well-child visit (newborn and infant): Clinical sciences
Well-child visit (toddler and child): Clinical sciences
Well-child visit (adolescent): Clinical sciences
Approach to a breast mass and asymmetry: Clinical sciences
Approach to breast pain (mastalgia): Clinical sciences
Approach to nipple discharge: Clinical sciences
Fibrocystic breast changes: Clinical sciences
Well-patient care (GYN): Clinical sciences
Cervical cancer screening: Clinical sciences
Approach to vulvar skin disorders: Clinical sciences
Approach to vaginal discharge: Clinical sciences
Sexually transmitted infection screening (GYN): Clinical sciences
Approach to primary amenorrhea: Clinical sciences
Approach to acute pelvic pain (GYN): Clinical sciences
Approach to dysmenorrhea: Clinical sciences
Approach to abnormal uterine bleeding in reproductive-aged patients: Clinical sciences
Approach to adnexal masses: Clinical sciences
Approach to hypertension: Clinical sciences
Approach to a murmur (pediatrics): Clinical sciences
Approach to congenital heart diseases (cyanotic): Clinical sciences
Approach to congenital heart diseases (acyanotic): Clinical sciences
Atrial fibrillation and atrial flutter: Clinical sciences
Congestive heart failure: Clinical sciences
Approach to dyspnea: Clinical sciences
Approach to chest pain: Clinical sciences
Aortic stenosis: Clinical sciences
Mitral stenosis: Clinical sciences
Hypertrophic cardiomyopathy: Clinical sciences
Approach to lower limb edema: Clinical sciences
Peripheral arterial disease and ulcers: Clinical sciences
Venous insufficiency and ulcers: Clinical sciences
Preconception care: Clinical sciences
Perinatal depression and anxiety: Clinical sciences
Antepartum care (third trimester): Clinical sciences
Antepartum care (second trimester): Clinical sciences
Antepartum care (first trimester): Clinical sciences
Venous thromboembolism in pregnancy: Clinical sciences
Approach to upper abdominal pain: Clinical sciences
Approach to periumbilical and lower abdominal pain: Clinical sciences
Approach to constipation: Clinical sciences
Approach to constipation (pediatrics): Clinical sciences
Approach to abdominal wall and groin masses: Clinical sciences
Approach to chronic abdominal pain (pediatrics): Clinical sciences
Approach to vomiting (pediatrics): Clinical sciences
Approach to diarrhea (pediatrics): Clinical sciences
Approach to melena and hematemesis (pediatrics): Clinical sciences
Well-patient care (geriatrics): Clinical sciences
Approach to unsteadiness, gait disturbance, or falls: Clinical sciences
Approach to dysarthria or dysphagia: Clinical sciences
Approach to gradual cognitive decline: Clinical sciences
Osteoporosis: Clinical sciences
Testicular cancer: Clinical sciences
Testicular torsion (pediatrics): Clinical sciences
Benign prostatic hypertrophy and prostate cancer: Clinical sciences
Approach to perianal problems: Clinical sciences
Inguinal hernias: Clinical sciences
Approach to dysuria: Clinical sciences
Approach to urinary incontinence (GYN): Clinical sciences
Approach to proteinuria (pediatrics): Clinical sciences
Urinary retention: Clinical sciences
Lower urinary tract infection: Clinical sciences
Approach to fatigue: Clinical sciences
Approach to unintentional weight loss: Clinical sciences
Approach to weakness (focal and generalized): Clinical sciences
Approach to a fever in the returned traveler: Clinical sciences

Decision-Making Tree

Transcript

Watch video only

Cyanotic congenital heart disease refers to structural heart lesions that cause significant blood oxygen desaturation and cyanosis. Cyanotic congenital heart lesions can be categorized according to their characteristic circulatory patterns, which include increased or decreased pulmonary blood flow, decreased systemic blood flow, or inadequate pulmonary-systemic mixing.

If a pediatric patient presents with a chief concern suggesting cyanotic congenital heart disease, perform an ABCDE assessment. Cyanosis indicates that your patient is unstable, so first stabilize the airway, breathing, and circulation. You may need to intubate and mechanically ventilate your patient. Next, obtain IV access, consider IV fluids, and begin continuous vital sign monitoring, including blood pressure, heart rate, and oxygen saturation. Finally, provide supplemental oxygen, if needed.

Next, obtain a focused history and physical exam, and measure pulse oximetry in the right hand, which measures pre-ductal saturation; and the feet, which measures post-ductal saturation. Pre- and postductal measurements allow you to compare oxygenation of the systemic circulation before and after the ductus arteriosus inserts into the aorta. If pre-ductal saturations are significantly higher than postductal saturations, it means that deoxygenated blood is being shunted from the pulmonary artery to the aorta, through an open ductus arteriosus. This is called differential cyanosis and suggests the presence of critical congenital heart disease.

Okay, you might find a family history of congenital heart disease, or there may have been a prenatal ultrasound demonstrating a heart defect. Exam findings include central cyanosis in areas like the lips and chest. Some patients may display signs of respiratory distress, like dyspnea or tachypnea, as well as a heart murmur or hepatomegaly.

Lastly, pulse oximetry measurements reveal an oxygen saturation below 90% in the right hand and feet, or a saturation below 95% in the right hand and feet on 3 separate occasions. You might also find a 3% difference in saturation between the right hand and foot on 3 separate occasions if the heart lesion is ductal-dependent.

With these findings, consider cyanotic congenital heart disease, so order a chest X-ray and an echocardiogram or echo, and assess the pulmonary and systemic blood flow.

Here’s a clinical pearl! When evaluating a newborn with cyanosis, consider primary lung disease. If echocardiography isn't available, you can use the hyperoxia test to distinguish congenital heart conditions from pulmonary conditions. To do this, obtain arterial blood gases before and after administering 100% oxygen. The PaO2 will rise by 150 mm mercury or more after hyperoxia if the newborn has pulmonary disease, but there will be little to no improvement in cyanotic heart lesions with a right-to-left intracardiac shunt.

Let’s move on to echocardiogram results, starting with patients with increased pulmonary blood flow. In this case, consider mixing lesions like total anomalous pulmonary venous drainage, or TAPVD, with obstruction, and truncus arteriosus.

Newborns with TAPVD with pulmonary venous obstruction develop profound respiratory distress with rapid deterioration. There is usually no murmur on exam but you may detect hepatomegaly. The chest X-ray typically demonstrates severe pulmonary vascular congestion, and the cardiac silhouette might have a "snowman" appearance. An echocardiogram confirms absent venous connections to the left atrium, with the pulmonary veins draining to the right atrium or to the superior or inferior vena cavae, along with obstruction of pulmonary venous drainage. Findings might also demonstrate an enlarged right atrium with a right-to-left shunt through an atrial septal defect, also called ASD, or through a patent foramen ovale, or PFO. These findings confirm TAPVD with obstruction.

Here’s a clinical pearl! Anomalous pulmonary venous return can be either partial, called PAPVD, where 1 or more pulmonary veins return to the left atrium; or total, called TAPVD, where no pulmonary veins return to the left atrium. While TAPVD with obstruction presents in the immediate newborn period with cyanosis and respiratory distress, TAPVD without obstruction may present later, during infancy or childhood, with gradual signs of heart failure and mild- to moderate oxygen desaturation. In contrast, PAPVD is an acyanotic defect that usually manifests in late childhood with signs suggestive of ASD.

Let’s move on to truncus arteriosus. Physical exam typically reveals a hyperdynamic precordium with a single loud S2, and bounding peripheral pulses. Some infants display distinctive facial and physical features suggesting DiGeorge syndrome, such as cleft lip and palate or hypertelorism. Occasionally, cyanosis and signs of heart failure like tachypnea and poor weight gain begin several months after birth. After the first week of life, chest X-ray typically reveals increased pulmonary vascularity, with a prominent ascending aorta, and sometimes, a right-sided aortic arch. Meanwhile, the echo will reveal a single arterial trunk supplying both the systemic and pulmonary circulations, with the truncal artery overlying a ventricular septal defect, or VSD; and a right-to-left shunt through the VSD. These findings confirm truncus arteriosus.

Let’s now discuss decreased pulmonary blood flow. Here, consider lesions like pulmonary atresia with intact ventricular septum, tetralogy of Fallot or TOF, tricuspid atresia, and Ebstein anomaly. Also, start an infusion of prostaglandin E1, or PGE1, to maintain a patent ductus arteriosus.

Here’s a high-yield fact! PGE1 provides a life-saving bridge to surgery in newborns with ductal-dependent lesions by promoting systemic-to-pulmonary mixing or by restoring systemic or pulmonary circulation. Avoid giving PGE1 to infants with increased pulmonary blood flow, since it can exacerbate pulmonary overcirculation.

Sources

  1. "Updated Strategies for Pulse Oximetry Screening for Critical Congenital Heart Disease" Pediatrics (2020)
  2. "Nelson Textbook of Pediatrics, 21st ed." Elsevier (2020)
  3. "Congenital Heart Disease" Pediatr Rev (2017)
  4. "Presentation of congenital heart disease in the neonate and young infant" Pediatr Rev (2007)